{
    "code": "02014434",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02014434",
    "time": "2020-02-25 10:42:42",
    "許可證字號": "衛署藥輸字第014434號",
    "註銷狀態": "已註銷",
    "註銷日期": "93\/11\/18",
    "註銷理由": "逾期未申覆",
    "製造許可登錄編號": "",
    "有效日期": "93\/10\/22",
    "發證日期": "74\/10\/22",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201443400",
    "中文品名": "衛可生凍晶注射劑１公絲",
    "英文品名": "VINCRISTINE PHARMACHEMIE 1MG FREEZE DRIED POWDER FOR INJECTION",
    "適應症": "淋巴肉瘤、何杰金氏病、網細胞肉瘤、急性白血病",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶附溶液",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "VINCRISTINE SULFATE",
    "限制項目": "02輸　入",
    "申請商名稱": "0513201100  民橋企業股份有限公司",
    "申請商地址": "台北巿八德路三段１５５巷４弄１０號",
    "主製造廠": [
        {
            "製造廠名稱": "FNL0029000  PHARMACHEMIE B.V.",
            "製造廠廠址": "NIJVERHEIDSWEG 48-50, HAARLEM P.O. BOX 552 2003",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1002000210",
            "成分名稱": "VINCRISTINE SULFATE",
            "含量描述": "(100%) 1",
            "含量": "",
            "單位": "MG"
        }
    ]
}